封面
市場調查報告書
商品編碼
1616702

適應原市場機會、成長動力、產業趨勢分析與預測 2024 - 2032

Adaptogens Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 205 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023 年,全球適應原市場價值為107.1 億美元,預計2024 年至2032 年複合年成長率為6.8%。的興趣,特別是那些緩解壓力並提高能量水平。隨著越來越多的人追求整體健康方法,適應原將成為首選。創新新創企業的湧入市場也對其發展發揮重要作用。適應原是幫助身體適應壓力源並提高恢復能力的天然物質。

它們在各種產品形式中都很受歡迎,包括補充劑、茶和零食。這種不斷成長的需求與預防性健康措施的更廣泛趨勢以及對天然成分的渴望相一致,進一步推動了市場擴張。適應原作為健康習慣的重要組成部分越來越受到關注,特別是當消費者優先考慮心理健康和福祉時。該市場預計將大幅成長,特別是由於對有助於壓力管理、頭腦清醒和整體健康的天然產品的需求不斷增加。

隨著消費者偏好轉向整體健康解決方案,將適應原納入日常生活變得越來越普遍。生產能力和零售店的擴張也促進了行業成長,提高了適應原產品對更廣泛受眾的可用性。阿什瓦甘達細分市場已成為適應原市場的關鍵參與者,由於其眾所周知的緩解壓力和增強能量的特性而受到巨大的需求。人們對阿育吠陀醫學和整體健康實踐日益成長的興趣進一步提高了其受歡迎程度,鞏固了其作為市場成長主要驅動力的地位。

市場範圍
開始年份 2023年
預測年份 2024-2032
起始值 107.1 億美元
預測值 194.5 億美元
複合年成長率 6.8%

預計到 2032 年,食品和飲料領域的複合年成長率將超過 6.5%。消費者擴大在花草茶、能量棒和旨在緩解壓力和保持頭腦清醒的飲料等產品中尋求天然成分。藥局通路在適應原市場中佔了很大佔有率,預計複合年成長率也將超過 6.5%。隨著越來越多的消費者轉向非處方保健產品,藥局正在成為適應原補充品的主要零售店。亞太地區在適應原市場中累積了顯著的佔有率,預計2024 年至2032 年複合年成長率將超過6.5% 這種成長是由印度和中國等國家豐富的傳統醫學歷史推動的,在這些國家,適應原草藥一直在使用。隨著電子商務平台的興起,消費者對適應原益處的認知不斷提高,這些產品變得更容易獲得,並有助於積極的市場前景。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
    • 價值鏈
    • 主要製造商
    • 前往市場路線
    • 主要經銷商
      • 新的分銷管道
    • 全行業利潤率
  • 產業影響力
    • 成長動力
    • 市場挑戰
    • 市場機會
      • 新市場/新應用
      • 成長潛力分析
  • 原料景觀
    • 製造趨勢
      • 技術演進
    • 各地區定價趨勢(美元/噸)
      • 北美洲
      • 歐洲
      • 亞太地區
      • 拉丁美洲
      • 中東和亞洲
  • 法規和市場影響
  • 波特的分析
  • PESTEL分析

第 4 章:競爭格局

  • 公司市佔率分析
  • 競爭定位矩陣
  • 戰略展望矩陣

第 5 章:市場規模與預測:按來源分類,2021-2032 年

  • 主要趨勢
  • 阿什瓦甘達
  • 黃耆
  • 聖羅勒
  • 紅景天
  • 五味子
  • 適應性蘑菇
  • 其他

第 6 章:市場規模與預測:依最終用途分類,2021-2032 年

  • 主要趨勢
  • 粉末
  • 膠囊
  • 茶和飲料
  • 其他

第 7 章:市場規模與預測:按應用分類,2021-2032 年

  • 主要趨勢
  • 食品和飲料來源
  • 膳食和運動補充劑
  • 製藥
  • 化妝品
  • 動物飼料

第 8 章:市場規模與預測:按配銷通路分類,2021-2032 年

  • 主要趨勢
  • 離線
    • 超市/大賣場
    • 藥局
    • 雜貨店和便利商店
  • 線上

第 9 章:市場規模與預測:按地區分類,2021-2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • MEA
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • MEA 的其餘部分

第 10 章:公司簡介

  • REBBL
  • Organic India
  • NutraScience Labs
  • Nutracap Labs
  • Organika Health Products Inc
  • PLT Health Solutions
  • Xi'an Greena Biotech Co. Ltd.
  • Organic Herb Inc
  • Xian Yuensun Biological Technology Co. Ltd.
  • UNO VETCHEM
簡介目錄
Product Code: 5189

The Global Adaptogens Market was valued at USD 10.71 billion in 2023 and is projected to grow at a CAGR of 6.8% from 2024 to 2032. This impressive growth is largely driven by increasing consumer awareness and a growing interest in natural health remedies, particularly those that relieve stress and boost energy levels. As more individuals pursue holistic approaches to health and wellness, adaptogens will emerge as a preferred choice. The influx of innovative start-ups in the market is also playing a significant role in its development. Adaptogens are natural substances that help the body adapt to stressors and promote resilience.

Their popularity is evident across various product forms, including supplements, teas, and snacks. This rising demand aligns with a broader trend toward preventive health measures and the desire for natural ingredients, further fueling market expansion. Adaptogens are gaining traction as essential components of wellness routines, particularly as consumers prioritize mental health and well-being. The market is set for substantial growth, particularly due to the increasing demand for natural products that aid in stress management, mental clarity, and overall wellness.

As consumer preferences shift towards holistic health solutions, the incorporation of adaptogens into daily routines is becoming more common. The expansion of production capabilities and retail outlets is also bolstering industry growth, enhancing the availability of adaptogen products to a broader audience. The ashwagandha segment has emerged as a key player in the adaptogens market, experiencing significant demand due to its well-known stress-relieving and energy-boosting properties. Its popularity is further enhanced by the growing interest in Ayurvedic medicine and holistic health practices, solidifying its position as a primary driver of market growth.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$10.71 Billion
Forecast Value$19.45 Billion
CAGR6.8%

The food and beverage segment is expected to register a robust CAGR of over 6.5% through 2032. The rising trend of functional foods and drinks that offer added health benefits is driving this growth. Consumers increasingly seek natural ingredients in products like herbal teas, energy bars, and beverages designed for stress relief and mental clarity. The drug store channel has accounted for a significant share of the adaptogens market, also projected to grow at over 6.5% CAGR. As more consumers turn to over-the-counter health products, drug stores are becoming key retail outlets for adaptogen supplements.The convenience and trust associated with these retailers are pivotal in driving this segment's growth. The Asia Pacific region accumulates a noteworthy share of the adaptogens market and is expected to grow at over 6.5% CAGR from 2024 to 2032. This growth is fueled by a rich history of traditional medicine in countries like India and China, where adaptogenic herbs have been utilized for centuries. Increasing consumer awareness of the benefits of adaptogens, along with the rise of e-commerce platforms, is making these products more accessible and contributing to a positive market outlook.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast calculation
  • 1.4 Data sources
    • 1.4.1 Primary
    • 1.4.2 Data Mining Sources
      • 1.4.2.1 Paid sources
      • 1.4.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Value chain
    • 3.1.2 Key manufacturers
    • 3.1.3 Go to market routes
    • 3.1.4 Key distributors
      • 3.1.4.1 New distribution channels
    • 3.1.5 Profit margins across the industry
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
    • 3.2.2 Market challenges
    • 3.2.3 Market opportunities
      • 3.2.3.1 New markets/applications
      • 3.2.3.2 Growth potential analysis
  • 3.3 Raw material landscape
    • 3.3.1 Manufacturing trends
      • 3.3.1.1 Technology evolution
    • 3.3.2 Pricing trend, by Region (USD/Ton)
      • 3.3.2.1 North America
      • 3.3.2.2 Europe
      • 3.3.2.3 Asia Pacific
      • 3.3.2.4 Latin America
      • 3.3.2.5 Middle East & Asia
  • 3.4 Regulations & market impact
  • 3.5 Porter's analysis
  • 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Company market share analysis
  • 4.2 Competitive positioning matrix
  • 4.3 Strategic outlook matrix

Chapter 5 Market Size and Forecast, By Source, 2021-2032 (USD Million, Kilo Tons)

  • 5.1 Key trends
  • 5.2 Ashwagandha
  • 5.3 Ginseng
  • 5.4 Astragalus
  • 5.5 Holy Basil
  • 5.6 Rhodiola Rosea
  • 5.7 Schisandra
  • 5.8 Adaptogenic mushrooms
  • 5.9 Others

Chapter 6 Market Size and Forecast, By End-use, 2021-2032 (USD Million, Kilo Tons)

  • 6.1 Key trends
  • 6.2 Powder
  • 6.3 Capsules
  • 6.4 Teas & beverages
  • 6.5 Others

Chapter 7 Market Size and Forecast, By Application, 2021-2032 (USD Million, Kilo Tons)

  • 7.1 Key trends
  • 7.2 Food & Beverage Sources
  • 7.3 Dietary & sports supplements
  • 7.4 Pharmaceutical
  • 7.5 Cosmetics
  • 7.6 Animal Feed

Chapter 8 Market Size and Forecast, By Distribution Channel, 2021-2032 (USD Million, Kilo Tons)

  • 8.1 Key trends
  • 8.2 Offline
    • 8.2.1 Supermarket/Hypermarket
    • 8.2.2 Drugstore
    • 8.2.3 Grocery & Convenience Store
  • 8.3 Online

Chapter 9 Market Size and Forecast, By Region, 2021-2032 (USD Million, Kilo Tons)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 India
    • 9.4.3 Japan
    • 9.4.4 South Korea
    • 9.4.5 Australia
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 MEA
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 South Africa
    • 9.6.4 Rest of MEA

Chapter 10 Company Profiles

  • 10.1 REBBL
  • 10.2 Organic India
  • 10.3 NutraScience Labs
  • 10.4 Nutracap Labs
  • 10.5 Organika Health Products Inc
  • 10.6 PLT Health Solutions
  • 10.7 Xi'an Greena Biotech Co. Ltd.
  • 10.8 Organic Herb Inc
  • 10.9 Xian Yuensun Biological Technology Co. Ltd.
  • 10.10 UNO VETCHEM